(BBWI) Bath & Body Works - Ratings and Ratios
Candles, Soaps, Lotion, Perfume, Sanitizer
BBWI EPS (Earnings per Share)
BBWI Revenue
Description: BBWI Bath & Body Works
Bath & Body Works Inc. (BBWI) is a leading specialty retailer in the home fragrance, personal care, and body care markets, offering a diverse range of products including candles, diffusers, fragrances, soaps, lotions, and creams under various brand names. The companys product portfolio is sold through a multi-channel approach, including retail stores and e-commerce platforms in the US and Canada, as well as through international partnerships.
To evaluate BBWIs performance, key performance indicators (KPIs) such as sales growth, same-store sales, gross margin, and operating margin are crucial. The companys ability to maintain a strong brand presence and adapt to changing consumer preferences will be essential in driving future growth. Additionally, metrics like inventory turnover, customer acquisition cost, and customer retention rate can provide insights into the companys operational efficiency and customer loyalty.
From a financial perspective, BBWIs market capitalization and price-to-earnings ratio indicate its market valuation. The companys return on equity (ROE) is negative, suggesting that it may be facing challenges in generating profits. However, a deeper analysis of the companys financial statements, including revenue growth, operating cash flow, and debt-to-equity ratio, would be necessary to understand its underlying financial health.
To further assess BBWIs prospects, it is essential to examine industry trends, competitive landscape, and the companys strategic initiatives. The growing demand for home fragrance and personal care products, driven by consumer preferences for wellness and self-care, presents opportunities for BBWI to expand its market share. The companys e-commerce capabilities, brand diversification, and international partnerships are also critical factors in its growth strategy.
BBWI Stock Overview
| Market Cap in USD | 5,819m |
| Sub-Industry | Other Specialty Retail |
| IPO / Inception | 1985-07-01 |
BBWI Stock Ratings
| Growth Rating | -32.0% |
| Fundamental | 69.7% |
| Dividend Rating | 60.8% |
| Return 12m vs S&P 500 | -23.6% |
| Analyst Rating | 3.85 of 5 |
BBWI Dividends
| Dividend Yield 12m | 2.84% |
| Yield on Cost 5y | 4.82% |
| Annual Growth 5y | 26.91% |
| Payout Consistency | 91.6% |
| Payout Ratio | 23.3% |
BBWI Growth Ratios
| Growth Correlation 3m | -39.8% |
| Growth Correlation 12m | -30.2% |
| Growth Correlation 5y | -15.4% |
| CAGR 5y | -9.44% |
| CAGR/Max DD 3y | -0.19 |
| CAGR/Mean DD 3y | -0.38 |
| Sharpe Ratio 12m | -0.58 |
| Alpha | 0.02 |
| Beta | 0.814 |
| Volatility | 49.98% |
| Current Volume | 7847.6k |
| Average Volume 20d | 6785.6k |
| Stop Loss | 24.4 (-5.2%) |
| Signal | -0.88 |
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income (728.0m TTM) > 0 and > 6% of Revenue (6% = 442.2m TTM) |
| FCFTA 0.16 (>2.0%) and ΔFCFTA 2.40pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 5.47% (prev 2.29%; Δ 3.18pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.21 (>3.0%) and CFO 1.00b > Net Income 728.0m (YES >=105%, WARN >=100%) |
| Net Debt (4.63b) to EBITDA (1.56b) ratio: 2.97 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.31 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (211.6m) change vs 12m ago -5.11% (target <= -2.0% for YES) |
| Gross Margin 44.60% (prev 44.01%; Δ 0.59pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 151.0% (prev 149.2%; Δ 1.76pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.42 (EBITDA TTM 1.56b / Interest Expense TTM 292.0m) >= 6 (WARN >= 3) |
Altman Z'' 0.91
| (A) 0.08 = (Total Current Assets 1.71b - Total Current Liabilities 1.30b) / Total Assets 4.81b |
| (B) -0.36 = Retained Earnings (Balance) -1.72b / Total Assets 4.81b |
| (C) 0.26 = EBIT TTM 1.29b / Avg Total Assets 4.88b |
| (D) -0.24 = Book Value of Equity -1.53b / Total Liabilities 6.36b |
| Total Rating: 0.91 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 69.65
| 1. Piotroski 7.50pt = 2.50 |
| 2. FCF Yield 8.21% = 4.11 |
| 3. FCF Margin 10.62% = 2.66 |
| 4. Debt/Equity data missing |
| 5. Debt/Ebitda 2.62 = -1.17 |
| 6. ROIC - WACC (= 35.37)% = 12.50 |
| 7. RoE data missing |
| 8. Rev. Trend -11.00% = -0.82 |
| 9. EPS Trend -2.42% = -0.12 |
What is the price of BBWI shares?
Over the past week, the price has changed by -8.63%, over one month by -14.10%, over three months by -4.51% and over the past year by -9.45%.
Is Bath & Body Works a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BBWI is around 24.16 USD . This means that BBWI is currently overvalued and has a potential downside of -6.1%.
Is BBWI a buy, sell or hold?
- Strong Buy: 7
- Buy: 4
- Hold: 8
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the BBWI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 40.7 | 58.3% |
| Analysts Target Price | 40.7 | 58.3% |
| ValueRay Target Price | 26.3 | 2.2% |
Last update: 2025-09-11 02:47
BBWI Fundamental Data Overview
CCE Cash And Equivalents = 364.0m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 8.4491
P/E Forward = 8.0645
P/S = 0.7894
P/EG = 0.8559
Beta = 1.458
Revenue TTM = 7.37b USD
EBIT TTM = 1.29b USD
EBITDA TTM = 1.56b USD
Long Term Debt = 3.89b USD (from longTermDebt, last quarter)
Short Term Debt = 194.0m USD (from shortTermDebt, last quarter)
Debt = 4.08b USD (Calculated: Short Term 194.0m + Long Term 3.89b)
Net Debt = 4.63b USD (from netDebt column, last quarter)
Enterprise Value = 9.54b USD (5.82b + Debt 4.08b - CCE 364.0m)
Interest Coverage Ratio = 4.42 (Ebit TTM 1.29b / Interest Expense TTM 292.0m)
FCF Yield = 8.21% (FCF TTM 783.0m / Enterprise Value 9.54b)
FCF Margin = 10.62% (FCF TTM 783.0m / Revenue TTM 7.37b)
Net Margin = 9.88% (Net Income TTM 728.0m / Revenue TTM 7.37b)
Gross Margin = 44.60% ((Revenue TTM 7.37b - Cost of Revenue TTM 4.08b) / Revenue TTM)
Tobins Q-Ratio = -6.22 (set to none) (Enterprise Value 9.54b / Book Value Of Equity -1.53b)
Interest Expense / Debt = 1.67% (Interest Expense 68.0m / Debt 4.08b)
Taxrate = 22.37% (230.0m / 1.03b)
NOPAT = 1.00b (EBIT 1.29b * (1 - 22.37%))
Current Ratio = 1.31 (Total Current Assets 1.71b / Total Current Liabilities 1.30b)
Debt / EBITDA = 2.62 (Net Debt 4.63b / EBITDA 1.56b)
Debt / FCF = 5.21 (Debt 4.08b / FCF TTM 783.0m)
Total Stockholder Equity = -1.53b (last 4 quarters mean)
RoA = 15.12% (Net Income 728.0m, Total Assets 4.81b )
RoE = unknown (Net Income TTM 728.0m / Total Stockholder Equity -1.53b)
RoCE = 54.78% (Ebit 1.29b / (Equity -1.53b + L.T.Debt 3.89b))
RoIC = 41.20% (NOPAT 1.00b / Invested Capital 2.43b)
WACC = 5.83% (E(5.82b)/V(9.90b) * Re(9.02%)) + (D(4.08b)/V(9.90b) * Rd(1.67%) * (1-Tc(0.22)))
Shares Correlation 3-Years: -93.13 | Cagr: -0.72%
Discount Rate = 9.02% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 73.32% ; FCFE base≈744.2m ; Y1≈683.3m ; Y5≈611.0m
Fair Price DCF = 44.90 (DCF Value 9.26b / Shares Outstanding 206.2m; 5y FCF grow -10.28% → 3.0% )
EPS Correlation: -2.42 | EPS CAGR: -2.80% | SUE: -0.15 | # QB: 0
Revenue Correlation: -11.00 | Revenue CAGR: -1.26% | SUE: N/A | # QB: None
Additional Sources for BBWI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle